RxDoctor Payments DataLook up a doctor →

Leigh Day, NP

Family · Gainesville, GANPI 1720327216

Payments from drug & device makers

$16,223in general payments, 2019–2025

Across 692 payments — averaging $23.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Merck$1K
  • AstraZeneca$1K
  • Bristol Myers Squibb$814
  • Daiichi Sankyo Inc.$668
  • E.r. Squibb & Sons, L.L.C.$651
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,81785%
  • Education$7254%
  • Other$1,68110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis66$2,675
Merck50$1,143
AstraZeneca(2 entities)43$1,027
Bristol Myers Squibb41$814
Daiichi Sankyo Inc.37$668
E.r. Squibb & Sons, L.L.C.36$651
Incyte Corporation31$630
Pfizer31$591
Johnson & Johnson(2 entities)26$588
Takeda Pharmaceuticals U.S.A., Inc.18$498
Regeneron Healthcare Solutions, Inc.16$462
GSK19$433
AbbVie19$424
Eisai Inc.18$415
Bayer18$403
Gilead(2 entities)15$300
Exelixis Inc.13$290
Seagen Inc.15$285
Pharmacyclics LLC, An Abbvie Company12$283
Genentech USA, Inc.13$256
Sanofi11$252
Lilly USA, LLC12$247
Tersera Therapeutics LLC9$212
Amgen10$194
Puma Biotechnology, Inc.10$188
Servier Pharmaceuticals LLC9$166
Jazz Pharmaceuticals Inc.7$158
Astellas Pharma US Inc5$151
AVEO Pharmaceuticals, Inc.5$142
Pharmaessentia USA Corporation6$136
EMD Serono, Inc.5$119
Sanofi-aventis U.S. LLC1$100
Rigel Pharmaceuticals, Inc.5$97
Coherus Oncology, Inc.5$88
Beone Medicines USA, Inc.4$79
Karyopharm Therapeutics Inc.3$74
Morphosys, US Inc.4$70
Sobi, Inc3$68
Stemline Therapeutics Inc.3$65
Array Biopharma Inc5$62
Caris MPI, Inc.2$56
Taiho Oncology, Inc.2$49
Deciphera Pharmaceuticals Inc.2$46
Adaptive Biotechnologies Corporation2$44
Mirati Therapeutics, Inc.2$44
Acrotech Biopharma Inc.2$42
Acceleron Pharma, Inc.2$40
Dova Pharmaceuticals2$40
Geron Corporation2$37
Dendreon Pharmaceuticals LLC1$36
Blueprint Medicines Corporation2$35
Sun Pharmaceutical Industries Inc.1$32
Azurity Pharmaceuticals, Inc.1$26
Tolmar, Inc.1$26
Immunogen, Inc.1$24
Sumitomo Pharma America, Inc.1$22
ADC Therapeutics America, Inc.1$20
Beigene USA, Inc.1$20
Legend Biotech USA Inc.1$20
Myovant Sciences Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,223 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Medicare billing

Part B allowed, 2024
$4,321
Medicare patients
33
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Exemestane11$856
Letrozole17$466
Potassium Chloride31$149
Anastrozole12$123
Prednisone13$60

Paid to pharmacies, not to this prescriber.

Other family in Gainesville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →